Security Snapshot

COGNITION THERAPEUTICS INC - Common Stock, par value $0.001 per share (CGTX) Institutional Ownership

CUSIP: 19243B102

13F Institutional Holders and Ownership History from Q4 2021 to Q3 2026

13F reference period

Q2 2026

Institutions Reporting

66

Shares (Excl. Options)

22.59MFull value: 22,587,135 · shares · 30 Jun 2026

Price

$1.15

The headline uses the Q2 2026 reference period after its reporting deadline. Available reports may still be incomplete or amended. Newer periods in the history table contain incoming reports and may be incomplete.

Save this security page for your next review

Watchlists follow companies and investors, across their share classes. Bookmark this page to revisit this specific CUSIP and its quarterly holders. If you create an account from here, we will bring you back after verification.

Create free account and return here Sign in and return here Review latest holder period
Security type / class
Equity / Common Stock, par value $0.001 per share
Symbol
CGTX on Nasdaq
All holders as of 30 Jun 2026
Q2 2026
Total 13F shares
22,587,135
Latest holder snapshot 5 signals
Total 13F value
$25,972,513
Portfolio coverage rank
0%
Share change
+1,167,442
Value change
+$1,646,508
Number of holders
66
Issuer context Names, identifiers, and filing context for this profile. 3 identity fields
Shares outstanding
87,819,638
SEC-reported price per share
$0.86
Insider filing price
$0.86
13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors
Filing notes and source

Key facts

  • CGTX - COGNITION THERAPEUTICS INC - Common Stock, par value $0.001 per share is tracked under CUSIP 19243B102.
  • 66 institutions reported positions in Q2 2026.
  • 1 significant owner is listed from Schedule 13D/13G reporting.

Change

  • Holder count moved from 74 to 66 between Q1 2026 and Q2 2026.
  • SEC-reported value moved from
    $16.26MFull value: $16,261,960 · USD · 31 Mar 2026
    to
    $25.97MFull value: $25,972,513 · USD · 30 Jun 2026
    .

Research use

  • You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
  • 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.

Evidence

Source: SEC Form 13F

Latest holder context comes from 66 institutions filings for Q2 2026.

Open SEC evidence

Security key

19243B102

13F reference period

Q2 2026

13F holders

66

13D/G owners

1

CIK / CUSIP context first

Open Q2 2026 holders CGTX full holder history COGNITION THERAPEUTICS INC SEC filings COGNITION THERAPEUTICS INC company facts COGNITION THERAPEUTICS INC insider transactions

Broader feeds

Latest 13F filings Latest 13D/G filings All securities

13D/G owners

Significant owners

Large-stake holder rows connected to Schedule 13D/G evidence.

Rows
1
Security
CGTX
Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
BIOS Memory SPV I, LP 6.9% $15,027,696 6,059,555 AARON G.L. FLETCHER 19 Sep 2025
As of 30 Jun 2026, 66 institutional investors reported holding
22.59MFull value: 22,587,135 · shares · 30 Jun 2026
shares of COGNITION THERAPEUTICS INC - Common Stock, par value $0.001 per share (CGTX). This represents 26% of the company’s total
87.82MFull value: 87,819,638 · shares · Stored outstanding share count
outstanding shares.

13F concentration

Top 25 institutional shareholders

Largest 13F positions for this security by reported shares and value.

Top holder share
25%
Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
BIOS Capital Management, LP 6.8% 6,000,000 0% 17% $6,900,001
DAVENPORT & Co LLC 4.9% 4,259,511 +47% 0.03% $4,898,438
VANGUARD CAPITAL MANAGEMENT LLC 3.9% 3,438,775 +15% 0% $3,954,591
BlackRock, Inc. 1.4% 1,261,993 +30% 0% $1,451,292
Chescapmanager LLC 1.1% 997,029 0% 0.15% $1,146,583
GEODE CAPITAL MANAGEMENT, LLC 1% 910,006 -1.1% 0% $1,047,051
RENAISSANCE TECHNOLOGIES LLC 0.79% 693,288 -38% 0% $797,281
Hilton Capital Management, LLC 0.63% 548,950 0% 0.04% $631,293
VANGUARD FIDUCIARY TRUST CO 0.58% 508,220 +9.6% 0% $584,453
CM Management, LLC 0.51% 450,000 +12% 0.33% $517,500
Dauntless Investment Group, LLC 0.42% 371,701 -14% 0.74% $427,456
Sigma Planning Corp 0.41% 362,265 +7.3% 0.01% $416,605
STATE STREET CORP 0.4% 348,983 +11% 0% $401,330
TOCQUEVILLE ASSET MANAGEMENT L.P. 0.36% 320,500 +64% 0% $368,575
UBS Group AG 0.25% 218,536 +184% 0% $251,316
AMERICAN FINANCIAL GROUP INC 0.23% 205,000 0% 0.08% $235,750
NORTHERN TRUST CORP 0.2% 178,202 +5.6% 0% $204,932
Voss Capital, LP 0.2% 175,000 -12% 0.01% $201,250
Texas Capital Bank Wealth Management Services Inc 0.16% 143,296 +16% 0.01% $164,790
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 0.1% 84,940 0% 0% $97,681
Virtu Financial LLC 0.1% 83,434 +19% 0% $96,000
XTX Topco Ltd 0.09% 78,471 -60% 0% $90,242
Corient Private Wealth LP 0.09% 78,226 +8.5% 0% $89,960
McAdam, LLC 0.07% 64,553 -7.7% 0% $74,236
FCA CORP /TX 0.06% 52,536 0% 0.01% $60,416

Quarter history

Institutional holders across reporting periods

Holder count, reported shares/value, and median price by quarter.

Periods
20
Headline period
Q2 2026
Rows shown
1-20 of 20
Period 13F Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2026 Q3 4,962,511 $4,761,445 +$18,785 $0.96 18
2026 Q2 22,587,135 $25,972,513 +$1,646,508 $1.15 66
2026 Q1 21,406,784 $16,261,960 -$482,537 $0.76 74
2025 Q4 21,425,389 $28,929,187 +$212,111 $1.35 79
2025 Q3 21,268,922 $28,723,974 +$14,962,053 $1.35 68
2025 Q2 11,168,930 $3,463,844 -$159,050 $0.31 45
2025 Q1 11,627,581 $4,889,933 +$37,435 $0.42 48
2024 Q4 11,088,340 $7,775,058 +$595,627 $0.70 44
2024 Q3 4,253,980 $1,990,924 -$2,451,158 $0.47 39
2024 Q2 5,310,353 $8,815,784 -$2,998,367 $1.66 46
2024 Q1 7,090,800 $12,904,468 -$197,637 $1.82 46
2023 Q4 7,154,013 $13,234,773 +$56,992 $1.85 36
2023 Q3 7,236,396 $10,419,453 +$193,944 $1.44 34
2023 Q2 7,100,887 $12,994,058 -$80,887 $1.83 34
2023 Q1 7,140,406 $14,140,001 +$282,877 $1.98 32
2022 Q4 4,800,813 $10,080,423 +$4,062,100 $2.10 32
2022 Q3 5,091,352 $9,669,716 +$1,037,445 $1.90 29
2022 Q2 4,504,385 $9,489,895 +$5,791,733 $2.11 27
2022 Q1 1,666,005 $4,577,000 +$779,768 $2.75 25
2021 Q4 1,334,704 $8,437,000 +$8,437,000 $6.32 18
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .